Marlene Smurzynski

2.2k total citations · 1 hit paper
24 papers, 1.7k citations indexed

About

Marlene Smurzynski is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Marlene Smurzynski has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 12 papers in Emergency Medicine and 10 papers in Virology. Recurrent topics in Marlene Smurzynski's work include HIV/AIDS Research and Interventions (17 papers), HIV-related health complications and treatments (12 papers) and HIV Research and Treatment (10 papers). Marlene Smurzynski is often cited by papers focused on HIV/AIDS Research and Interventions (17 papers), HIV-related health complications and treatments (12 papers) and HIV Research and Treatment (10 papers). Marlene Smurzynski collaborates with scholars based in United States, Uganda and Kenya. Marlene Smurzynski's co-authors include Ronald J. Bosch, Ann C. Collier, Kunling Wu, Ronald J. Ellis, Scott Evans, Kevin R. Robertson, Justin C. McArthur, Julia Wu, Thomas D. Parsons and William C. Miller and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Journal of the American Society of Nephrology.

In The Last Decade

Marlene Smurzynski

23 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prevalence and incidence of neurocognitive impairment in the HAART era

2007 504 citations Kevin R. Robertson, Marlene Smurzynski et al. AIDS profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marlene Smurzynski United States	17	1.0k	889	755	304	183	24	1.7k
Frank de Wolf Netherlands	18	1.3k 1.2×	726 0.8×	676 0.9×	780 2.6×	174 1.0×	35	2.1k
Lorie Benning United States	22	936 0.9×	493 0.6×	858 1.1×	579 1.9×	164 0.9×	44	1.9k
Stephen Taylor United Kingdom	29	1.5k 1.4×	1.1k 1.2×	289 0.4×	652 2.1×	99 0.5×	79	2.4k
Edwina Wright Australia	19	1.1k 1.1×	605 0.7×	264 0.3×	731 2.4×	211 1.2×	60	1.6k
Jaime H. Vera United Kingdom	22	726 0.7×	557 0.6×	596 0.8×	348 1.1×	108 0.6×	118	1.5k
Luuk Gras Netherlands	25	1.2k 1.1×	789 0.9×	346 0.5×	844 2.8×	110 0.6×	54	2.3k
Allen McCutchan United States	17	542 0.5×	457 0.5×	146 0.2×	348 1.1×	248 1.4×	27	1.2k
Hartmut B. Krentz Canada	19	893 0.9×	489 0.6×	346 0.5×	537 1.8×	215 1.2×	46	1.3k
Christine Alden United States	7	381 0.4×	252 0.3×	314 0.4×	233 0.8×	85 0.5×	7	781
Michelle Floris-Moore United States	23	706 0.7×	326 0.4×	805 1.1×	346 1.1×	148 0.8×	51	1.5k

Countries citing papers authored by Marlene Smurzynski

Since Specialization

Citations

This map shows the geographic impact of Marlene Smurzynski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Smurzynski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Smurzynski more than expected).

Fields of papers citing papers by Marlene Smurzynski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Smurzynski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Smurzynski. The network helps show where Marlene Smurzynski may publish in the future.

Co-authorship network of co-authors of Marlene Smurzynski

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Smurzynski. A scholar is included among the top collaborators of Marlene Smurzynski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Smurzynski. Marlene Smurzynski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robertson, Kevin, Marlene Smurzynski, Supriya Krishnan, et al.. (2017). Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen. AIDS. 31(11). 1565–1571. 22 indexed citations

Kang, Minhee, Kimberly Hollabaugh, Susan L. Koletar, et al.. (2014). Virologic and Serologic Outcomes of Mono Versus Dual HBV Therapy and Characterization of HIV/HBV Coinfection in a US Cohort. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(2). 172–180. 11 indexed citations

Overton, Edgar T., Douglas Kitch, Constance A. Benson, et al.. (2013). Effect of Statin Therapy in Reducing the Risk of Serious Non-AIDS-Defining Events and Nonaccidental Death. Clinical Infectious Diseases. 56(10). 1471–1479. 50 indexed citations

Smurzynski, Marlene, Kunling Wu, Jeffrey T. Schouten, et al.. (2013). Factors associated with remaining on initial randomized efavirenz-containing regimens. AIDS. 27(12). 1887–1897. 2 indexed citations

Bruggeman, Leslie A., John F. O’Toole, Michael D. Ross, et al.. (2013). Plasma Apolipoprotein L1 Levels Do Not Correlate with CKD. Journal of the American Society of Nephrology. 25(3). 634–644. 65 indexed citations

Krishnan, Supriya, Kun Wu, Marlene Smurzynski, et al.. (2011). Incidence Rate of and Factors Associated with Loss to Follow-up in a Longitudinal Cohort of Antiretroviral-Treated HIV-Infected Persons: An AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) Analysis. HIV Clinical Trials. 12(4). 190–200. 39 indexed citations

Ribaudo, Heather J., Constance A. Benson, Yu Zheng, et al.. (2011). No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT. Clinical Infectious Diseases. 52(7). 929–940. 114 indexed citations

Linas, Benjamin P., Marlene Smurzynski, Elena Losina, et al.. (2010). The impact of HIV/HCV co‐infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. Journal of Viral Hepatitis. 18(7). 506–512. 30 indexed citations

Smurzynski, Marlene, Kunling Wu, Constance A. Benson, et al.. (2010). Relationship Between CD4+ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(1). 117–127. 17 indexed citations

10.

Smurzynski, Marlene, Kunling Wu, Scott Letendre, et al.. (2010). Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. AIDS. 25(3). 357–365. 165 indexed citations

11.

Brown, Todd T., Marlene Smurzynski, Kunling Wu, Ronald J. Bosch, & Grace A. McComsey. (2009). Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort. Antiviral Therapy. 14(6). 853–858. 5 indexed citations

12.

Patterson, Kristine B., et al.. (2009). Treatment Responses in Antiretroviral Treatment–Naive Premenopausal and Postmenopausal HIV‐1–Infected Women: An Analysis from AIDS Clinical Trials Group Studies. Clinical Infectious Diseases. 49(3). 473–476. 16 indexed citations

13.

Kalayjian, Robert C., Nora Franceschini, Samir K. Gupta, et al.. (2008). Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS. 22(4). 481–487. 90 indexed citations

14.

Smurzynski, Marlene, Ann C. Collier, Susan L. Koletar, et al.. (2008). AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT): Rationale, Design, and Baseline Characteristics. HIV Clinical Trials. 9(4). 269–282. 72 indexed citations

15.

Gupta, Samir K., Marlene Smurzynski, Nora Franceschini, et al.. (2008). The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era. Antiviral Therapy. 14(4). 543–549. 27 indexed citations

16.

Ford, Chandra L., William C. Miller, Marlene Smurzynski, & Peter A. Leone. (2007). Key Components of A Theory–Guided HIV Prevention Outreach Model: Pre–Outreach Preparation, Community Assessment, and a Network of Key Informants. AIDS Education and Prevention. 19(2). 173–186. 11 indexed citations

17.

Robertson, Kevin R., Marlene Smurzynski, Thomas D. Parsons, et al.. (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 21(14). 1915–1921. 504 indexed citations breakdown →

18.

Tilson, Elizabeth Cuervo, Victoria Sánchez, Chandra L. Ford, et al.. (2004). Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions. BMC Public Health. 4(1). 21–21. 161 indexed citations

19.

Hightow‐Weidman, Lisa, William C. Miller, Peter A. Leone, et al.. (2004). Predictors of Repeat Testing and HIV Seroconversion in a Sexually Transmitted Disease Clinic Population. Sexually Transmitted Diseases. 31(8). 455–459. 16 indexed citations

20.

Hightow‐Weidman, Lisa, William C. Miller, Peter A. Leone, et al.. (2003). Failure To Return for HIV Posttest Counseling in an STD Clinic Population. AIDS Education and Prevention. 15(3). 282–290. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact